Newly diagnosed Venous Thromboembolism (VTE) patients want to know that they’ll be given the best possible treatment. When patients see that ELIQUIS is the #1 Oral Anti Coagulant (OAC), they’ll feel more confident about ELIQUIS’ ability to treat their VTE, driving them to ask their doctor about being on the #1 VTE drug.